Start the conversation
Developing effective vaccines against a deadly global pandemic is certainly bullish for a stock.
Indeed, Moderna and Pfizer shareholders have put away as much as 516% and 51% gains, respectively.
And when a lot of investors see this, they fear they’ve missed out.
Well, Michael’s here to assure you that you haven’t; not by a long shot.
And today, he’s got a vaccine stock you should put at the top of your “must-buy” list for the week ahead… .